| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |